Premium
Different types of allospecific CTL clones identified by their ability to recognize peptide loading‐defective target cells
Author(s) -
Aosai Fumie,
Öhlen Claes,
Ljunggren HansGustaf,
Höglund Petter,
Franksson Lars,
Ploegh Hidde,
Townsend Alain,
Kärre Kias,
Stauss Hans J.
Publication year - 1991
Publication title -
european journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.272
H-Index - 201
eISSN - 1521-4141
pISSN - 0014-2980
DOI - 10.1002/eji.1830211118
Subject(s) - ctl* , biology , mhc class i , major histocompatibility complex , cytotoxic t cell , lysis , mutant , antigen presentation , microbiology and biotechnology , peptide , antigen , immunology , genetics , in vitro , biochemistry , gene
Abstract Allospecific immune responses against the MHC of another individual are remarkably strong, due to a high number of responding T cell clones. Although it has been demonstrated that some allospecific cytotoxic T lymphocytes (CTL) recognize peptides presented by allogeneic MHC class I molecules, it has remained unclear whether MHC molecules can be recognized directly. We used the H‐2 b ‐derived murine lymphoma mutant RMA‐S, which has a defect affecting peptide loading of class I molecules, to test whether recognition by allospecific CTL always requires the presence of peptides. Three types of anti‐H‐2K b CTL clones can be distinguished by their ability to lyse RMA‐S target cells. Type A CTL clones efficiently lyse these target cells, the lysis by type B CTL clones is inefficient, and type C clones fail to lyse RMA‐S. Up‐regulation of the levels of H‐2K b density improved lysis by type B clones, but did not lead to lysis by type C clones. Some type A and B CTL clones apparently can recognize class I molecules devoid of peptides, while others are likely to recognize peptides which are not affected by the presentation defect of RMA‐S. We suggest that type C clones are specific for peptides which are not presented by the mutant cells. The results show that the majority of alloreactive CTL recognize peptide/MHC complexes, while some CTL behave as if they can recognize class I molecules in the absence of MHC‐bound peptides.